-
1
-
-
0037038364
-
Toxic oxygen: The radical life-giver
-
D. Abele Toxic oxygen: the radical life-giver Nature 420 2002 27
-
(2002)
Nature
, vol.420
, pp. 27
-
-
Abele, D.1
-
5
-
-
2942572700
-
Measuring reactive oxygen species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean?
-
B. Halliwell, and M. Whiteman Measuring reactive oxygen species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Brit J Pharmacol 142 2004 231 255
-
(2004)
Brit J Pharmacol
, vol.142
, pp. 231-255
-
-
Halliwell, B.1
Whiteman, M.2
-
6
-
-
0033950261
-
Biomarkers, bioindicators or ecotranslators with oestrogen mimics
-
A. Wiseman, P.S. Goldfarb, T.J. Ridgway, and H. Wiseman Biomarkers, bioindicators or ecotranslators with oestrogen mimics Trends Biotechnol 18 2000 1
-
(2000)
Trends Biotechnol
, vol.18
, pp. 1
-
-
Wiseman, A.1
Goldfarb, P.S.2
Ridgway, T.J.3
Wiseman, H.4
-
7
-
-
0036140873
-
The visible way
-
D. Bradley The visible way Chem Brit 38 2002 18
-
(2002)
Chem Brit
, vol.38
, pp. 18
-
-
Bradley, D.1
-
9
-
-
0035177609
-
Biomonitoring, ecoextrapolation then bioremediation for ecorestoration
-
A. Wiseman, and P.S. Goldfarb Biomonitoring, ecoextrapolation then bioremediation for ecorestoration Trends Biotechnol 19 2000 7 8
-
(2000)
Trends Biotechnol
, vol.19
, pp. 7-8
-
-
Wiseman, A.1
Goldfarb, P.S.2
-
12
-
-
0035426534
-
Do "fail-clean" biostrategies deliver "fail-safe" outcomes?
-
A. Wiseman, P.S. Goldfarb, and T. Ridgway Do "fail-clean" biostrategies deliver "fail-safe" outcomes? Trends Biotechnol 19 2001 287
-
(2001)
Trends Biotechnol
, vol.19
, pp. 287
-
-
Wiseman, A.1
Goldfarb, P.S.2
Ridgway, T.3
-
13
-
-
13444269104
-
Uncertainty in predictions of climate response to rising levels of greenhouse gases
-
D.A. Stainforth, T. Alna, C. Christensen, M. Collins, and N. Faull Uncertainty in predictions of climate response to rising levels of greenhouse gases Nature 433 2005 403 406
-
(2005)
Nature
, vol.433
, pp. 403-406
-
-
Stainforth, D.A.1
Alna, T.2
Christensen, C.3
Collins, M.4
Faull, N.5
-
14
-
-
0034628501
-
Directed evolution of new catalytic activity using the α/β-barrel scaffold
-
M.N. Altamirano, J.M. Blackburn, C. Aguayo, and A.R. Fersht Directed evolution of new catalytic activity using the α/β-barrel scaffold Nature 403 2000 617 622
-
(2000)
Nature
, vol.403
, pp. 617-622
-
-
Altamirano, M.N.1
Blackburn, J.M.2
Aguayo, C.3
Fersht, A.R.4
-
16
-
-
0036602161
-
Can "real-lab" supersede "virtual-ligand" promises?
-
A. Wiseman, and L.F.J. Woods Can "real-lab" supersede "virtual-ligand" promises? Trends Pharmacol Sci 23 2002 261
-
(2002)
Trends Pharmacol Sci
, vol.23
, pp. 261
-
-
Wiseman, A.1
Woods, L.F.J.2
-
18
-
-
21844432918
-
Rac 1b and reacrive oxygen species mediate MMP-3 induced EMT and genomic instability
-
D.C. Radisky, D.D. Levy, and L.E. Littlepage Rac 1b and reacrive oxygen species mediate MMP-3 induced EMT and genomic instability Nature 436 2005 123 125
-
(2005)
Nature
, vol.436
, pp. 123-125
-
-
Radisky, D.C.1
Levy, D.D.2
Littlepage, L.E.3
-
19
-
-
24344456496
-
Medicine gets personalised
-
A. Scott Medicine gets personalised Chem World 2 2005 32 34
-
(2005)
Chem World
, vol.2
, pp. 32-34
-
-
Scott, A.1
-
20
-
-
15044356152
-
Surveillance team against cancer
-
G. Klein Surveillance team against cancer Nature 434 2005 150
-
(2005)
Nature
, vol.434
, pp. 150
-
-
Klein, G.1
-
21
-
-
5644301009
-
Gene therapy for the circumvention of inborn errors of metabolism (IEM) caused by single-nucleotide-polymorphisms (SNPs)
-
A. Wiseman Gene therapy for the circumvention of inborn errors of metabolism (IEM) caused by single-nucleotide-polymorphisms (SNPs) Med Hypotheses 63 2004 810 812
-
(2004)
Med Hypotheses
, vol.63
, pp. 810-812
-
-
Wiseman, A.1
-
22
-
-
13444301289
-
Elimination of major side effects due to ROS of therapeuticals through biotransformation control of the 57 cytochromes P450 isoenzymes
-
A. Wiseman Elimination of major side effects due to ROS of therapeuticals through biotransformation control of the 57 cytochromes P450 isoenzymes Med Hypotheses 64 2005 802 805
-
(2005)
Med Hypotheses
, vol.64
, pp. 802-805
-
-
Wiseman, A.1
-
23
-
-
27744594482
-
Oxaliplatin and targeted adjunct chemotherapy for bowel cancer through DNA binding: Causal involvement of ROS
-
A. Wiseman, and P.S. Goldfarb Oxaliplatin and targeted adjunct chemotherapy for bowel cancer through DNA binding: causal involvement of ROS J Appl Ther Res 5 2005 24 31
-
(2005)
J Appl Ther Res
, vol.5
, pp. 24-31
-
-
Wiseman, A.1
Goldfarb, P.S.2
|